PharMerica Sends Letter to Omnicare; PharMerica's Board Says Offer Not in Best Intersts of Holders

by Matthew Kennedy, Benzinga Staff Writer
August 24, 2011 5:14 PM | 14 seconds read |
PharMerica Corporation PMC today sent a letter to Omnicare, Inc. OCR regarding the previously received and rejected unsolicited conditional proposal from Omnicare to acquire PharMerica for $15.00 per share in cash, subject to due diligence and regulatory approvals.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsM&AHealth CareHealth Care DistributorsHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!